CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients: a PK Pilot Study
Latest Information Update: 04 Nov 2025
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalic inclusion disorders
- Focus Pharmacodynamics
Most Recent Events
- 31 Oct 2025 Status changed from not yet recruiting to recruiting.
- 08 Sep 2025 Planned initiation date changed from 31 Aug 2025 to 1 Oct 2025.
- 08 Aug 2025 New trial record